Try our Advanced Search for more refined results

EU Pharma Probe Expected To Veer From FTC Course

By Sara Stefanini (January 22, 2008, 12:00 AM EST) -- While the European Commission appears to have taken a cue from the U.S. Federal Trade Commission in cracking down on potential antitrust issues and patent abuse in the pharmaceutical industry, the EC's inquiry began in a unique fashion: with unannounced dawn raids typically reserved for cartels. The approach of the EC is likely to differ from that of the U.S. in other ways, too, attorneys say....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!